Holocene Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,200,000
Closed -$133M 813
2025
Q2
$133M Buy
+1,200,000
New +$128M 0.32% 86
2021
Q2
Sell
-1,440,000
Closed -$93.1M 871
2021
Q1
$93.1M Buy
1,440,000
+480,000
+50% +$31M 0.58% 51
2020
Q4
$55.9M Buy
+960,000
New +$57.9M 0.35% 95

Other funds holding GILD

Holocene Advisors's GILD Position: Q1 2026 in Review

Holocene Advisors reduced its Gilead Sciences (GILD) stake by 37% in Q1 2026, selling an estimated $217M and leaving 2,611,826 shares worth $364M. The position accounts for 0.88% of the portfolio, ranked #22.

Holocene Advisors first reported a position in GILD in Q4 2017 and has held it in 10 quarters since. The position peaked at $511M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Holocene Advisors held 2,611,826 shares of Gilead Sciences worth $364M as of Q1 2026.
  • Holocene Advisors sold 1,552,612 Gilead Sciences shares in Q1 2026, an estimated $217M.
  • Gilead Sciences made up 0.88% of Holocene Advisors's portfolio in Q1 2026, its #22 holding.
  • Holocene Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 10 quarters since.
  • Holocene Advisors's Gilead Sciences position peaked at $511M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.